Ethyreal Bio Raises $101M as Investors Back New Approach to Graves’ and Thyroid Eye Disease

Cambridge, Mass.-based Ethyreal Bio has emerged from stealth with $101 million in financing, as investors back a new generation of... Read More

The post Ethyreal Bio Raises $101M as Investors Back New Approach to Graves’ and Thyroid Eye Disease appeared first on citybiz.